Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

Clinical trial NCT03173248 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03173248
Sponsor: Institut de Recherches Internationales Servier
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed Acute Myeloid Leukemia (AML)Untreated AML AML Arising From Myelodysplastic Syndrome (MDS)Leukemia, Myeloid, Acute

Start date: 2017-06-26
Primary completion: 2021-03-18
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.